Antiplatelet Agents for Stroke Prevention
Authors:
Open Access
- 1 July 2011
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 8 (3) , 475-487
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent StrokeNew England Journal of Medicine, 2008
- Update to the AHA/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic AttackStroke, 2008
- Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIAStroke, 2008
- Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic AttackStroke, 2006
- Antiplatelet Drugs In the Secondary Prevention After StrokeStroke, 2006
- Indications for Early Aspirin Use in Acute Ischemic StrokeStroke, 2000
- Ischemic Stroke SubtypesStroke, 2000
- "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.Stroke, 1983